First In Human Study of CX-801 in Advanced Solid Tumors
First In Human Study of CX-801 in Advanced Solid Tumors
Recruiting · NCT06462794 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First In Human Study of CX-801 in Advanced Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 | 2026-08-28 | NCT06462794 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CytomX Therapeutics | 2 |
| Merck Sharp & Dohme LLC | 650 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Scri Oncology Partners | Nashville | United States | 156 |
| START Dallas Fort Worth, LLC | Fort Worth | United States | 3 |
| The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate | Los Angeles | United States | 4 |
| The Melanoma and Skin Cancer Institute | Englewood | United States | 76 |
| University of Pittsburgh Hillman Cancer Center | Pittsburgh | United States | 3 |